During the past decade, Panax Clinical Research conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 10 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 8 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Panax Clinical Research" #1 sponsor was "Allergan" with 4 trials, followed by "AZTherapies, Inc." with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Panax Clinical Research" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Catalyst Clinical Research, LLC" with 1 trials as a collaborator, "Clinical Research Management, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Panax Clinical Research" are "COVID-19" (3 trials), "Non-Alcoholic Fatty Liver Disease" (3 trials), "Alzheimer Disease" (2 trials), "Chronic Gout" (2 trials) and "Diabetic Gastroparesis" (2 trials). Many other conditions were trialed in "Panax Clinical Research" in a lesser frequency.

Most popular intervention types in "Panax Clinical Research" are "Drug" (35 trials), "Other" (11 trials), "Biological" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "ALT-801" (2 trials), "ALZT-OP1a" (2 trials), "ALZT-OP1b" (2 trials) and "BI 685509" (2 trials). Other intervention names were less common.

The vast majority of trials in "Panax Clinical Research" are 38 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Panax Clinical Research". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Panax Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Panax Clinical Research, 10 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".